Bioceres reports 20% revenue decline in Q2025 FYXNUMX

Performance affected by adverse conditions in Argentina; North America and Brazil show growth

12.11.2024 | 08:35 (UTC -3)
Cultivar Magazine

Bioceres Crop Solutions today reported financial and operating results for the first quarter of fiscal 2025, ended September 30, 2024. Total revenue for the quarter was $93,3 million, down 20% from the same period last year ($116,6 million).

Performance was particularly impacted by adverse conditions in the Argentine market, where the start of the summer harvest was marked by delayed rains and last-minute purchasing behavior by farmers.

Despite the difficulties in the Argentine market, Bioceres made significant progress in other regions. Positive performance in the United States, Brazil and Mexico helped to mitigate some of the negative impacts. In particular, there was growth in sales of bioprotection products and adjuvants, as well as commercial expansion in Mexico.

Another highlight was the regulatory approval for the production of HB4 soybeans in Uruguay and Bolivia, which marks the full release of this technology in all soybean-producing countries in the Americas, according to information from the company.

Additionally, RinoTec technology received the EPA's Green Chemistry Challenge Award in the Safer and Degradable Chemical Design category, reinforcing Bioceres' commitment to sustainable solutions for agriculture.

The company's gross margin increased from 38,6% in the first quarter of 2024 to 40,2% in 2025, reflecting a strategic focus on higher margin products and more favorable cash conversion cycles.

Selling, general and administrative costs totaled US$26,7 million, a slight increase from the prior year, due to transitory effects such as import taxes on raw materials in Argentina.

Cultivar Newsletter

Receive the latest agriculture news by email